Literature DB >> 24931057

Prescription opioid abuse and tampering in the United States: results of a self-report survey.

Jeffrey Vietri1, Ashish V Joshi, Alexandra I Barsdorf, Jack Mardekian.   

Abstract

OBJECTIVE: The objective of this study is to estimate the prevalence and impact of prescription opioid abuse and tampering among US adults.
METHODS: Participants from the US National Health and Wellness Survey were invited to complete an online survey assessing use, misuse, and abuse of prescription opioid medications in the preceding 3 months. A total of 25,864 adults were screened for self-reported opioid abuse. Prevalence was calculated using weights based on age, gender, race, and education. Respondents reporting abuse or medical use of prescription opioid medication in the prior 3 months (N = 1,242) completed a questionnaire assessing health care resource use and the Work Productivity and Activity Impairment questionnaire.
RESULTS: The prevalence of prescription opioid abuse in the 3 months prior to the survey was estimated at 1.31% of US adults, with approximately half (0.67%) tampering during that time. Opioid abuse increased with younger age, male sex, minority race, psychiatric illness, alcoholism, cigarette smoking, being employed, and higher household income. Respondents abusing opioid medications reported greater impairment in work and nonwork activities and more health care use than nonusers. Tampering with opioid medication was associated with greater productivity loss and increased use of health care (all P < 0.05).
CONCLUSIONS: Tampering with opioid medications to get high is associated with substantial loss of productivity and health care use. Technologies that reduce users' ability to tamper may reduce the burden of opioid abuse on the health care system. Wiley Periodicals, Inc.

Entities:  

Keywords:  Abuse; Opioids; Substance Abuse

Mesh:

Year:  2014        PMID: 24931057     DOI: 10.1111/pme.12475

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  10 in total

1.  Frequency, Predictors, and Medical Record Documentation of Chemical Coping Among Advanced Cancer Patients.

Authors:  Jung Hye Kwon; Kimberson Tanco; Ji Chan Park; Angelique Wong; Lisa Seo; Diane Liu; Gary Chisholm; Janet Williams; David Hui; Eduardo Bruera
Journal:  Oncologist       Date:  2015-05-01

2.  Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors.

Authors:  Joseph J Palamar; Jenni A Shearston; Eric W Dawson; Pedro Mateu-Gelabert; Danielle C Ompad
Journal:  Drug Alcohol Depend       Date:  2015-11-21       Impact factor: 4.492

3.  Psychosocial risks of prescription drug misuse among U.S. racial/ethnic minorities: A systematic review.

Authors:  Bridgette J Peteet
Journal:  J Ethn Subst Abuse       Date:  2017-11-27       Impact factor: 1.507

Review 4.  Health harms of non-medical prescription opioid use: A systematic review.

Authors:  Dan Werb; Ayden I Scheim; Ayorinde Soipe; Samantha Aeby; Indhu Rammohan; Benedikt Fischer; Scott E Hadland; Brandon D L Marshall
Journal:  Drug Alcohol Rev       Date:  2022-04-18

5.  The health insurance industry: perpetuating the opioid crisis through policies of cost-containment and profitability.

Authors:  Michael E Schatman; Lynn R Webster
Journal:  J Pain Res       Date:  2015-03-18       Impact factor: 3.133

6.  Cost of opioid medication abuse with and without tampering in the USA.

Authors:  Jeffrey Vietri; Elizabeth T Masters; Alexandra I Barsdorf; Jack Mardekian
Journal:  Clinicoecon Outcomes Res       Date:  2018-08-10

7.  Addressing Opioid-Related Chemical Coping in Long-Term Opioid Therapy for Chronic Noncancer Pain: A Multicenter, Observational, Cross-Sectional Study.

Authors:  Anyela Marcela Castañeda; Chang-Soon Lee; Yong-Chul Kim; Dasom Lee; Jee Youn Moon
Journal:  J Clin Med       Date:  2018-10-14       Impact factor: 4.241

8.  Dependence to legally prescribed opioid analgesics in a university hospital in Medellin-Colombia: an observational study.

Authors:  Maria G Garcia-Orjuela; Lineth Alarcon-Franco; Juan C Sanchez-Fernandez; Yuli Agudelo; Andres F Zuluaga
Journal:  BMC Pharmacol Toxicol       Date:  2016-09-14       Impact factor: 2.483

Review 9.  Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies.

Authors:  Richard L Rauck
Journal:  Pain Pract       Date:  2019-02-28       Impact factor: 3.183

10.  Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER.

Authors:  Stevan Geoffrey Severtson; Scott E D Kreider; Elise C Amioka; Zachary R Margolin; Janetta L Iwanicki; Richard C Dart
Journal:  Pain Med       Date:  2020-12-25       Impact factor: 3.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.